400 filings
Page 15 of 20
6-K
4s0 0tbnzdq27q9
14 Sep 16
Acasti Pharma Reports Positive CaPre Omega-3 Bridging Study Data
12:00am
6-K
66q711v4zj81jye
5 Aug 16
Acasti Pharma Inc. 6-K
12:00am
6-K
b5462k nza
15 Jul 16
Acasti Announces the Election of its Directors, Change of Fiscal Year End and Other Related Matters Passed at its AGM
12:00am
6-K
l91t32
14 Jul 16
Current report (foreign)
12:00am
6-K
t3ond0hfr1y waabqe0l
11 Jul 16
Current report (foreign)
12:00am
6-K
ksbpy1qsh h87ckn2
11 Jul 16
Acasti Announces First Quarter Results
12:00am
6-K
b7d07b6c7
14 Jun 16
Notice of Annual and Special Meeting of Shareholders
12:00am
6-K
eje mfi4iw
31 May 16
Acasti Announces Grant of Stock Options
12:00am
6-K
78d6zfuabeh3
26 May 16
Acasti Pharma Inc. 6-K
12:00am
6-K
lr6 185cv7d
25 May 16
Acasti Announces Fourth Quarter and Fiscal Year Results
12:00am
6-K
i86hg
12 May 16
Jan D'Alvise Appointed President & CEO of Acasti Pharma
12:00am
6-K
0mgwdszsq92j3wk6r14
28 Mar 16
Acasti Pharma Inc. 6-K
12:00am
6-K
hy9cletf2f3o7dqno344
1 Mar 16
Acasti Announces Management Appointment and Changes to the Board of Directors
12:00am
6-K
7ow1a2zcr 273qlc8i
5 Feb 16
Acasti Pharma Inc. 6-K
12:00am
6-K
byq1 zhyp08o
19 Jan 16
Current report (foreign)
12:00am
6-K
q0vwnacdzj0qo0td
12 Jan 16
Current report (foreign)
12:00am
6-K
r3yru0o
12 Jan 16
Acasti Announces Third Quarter Results
12:00am
6-K
7jf9cxhk 4x7jf
8 Jan 16
Acasti & Neptune Enter Into Transactional Arrangement & Sign Operational Agreements
12:00am
6-K
u4xsq3v8
16 Dec 15
Acasti Provides Update on CaPreĀ® Development Pathway
12:00am